Loading viewer...
investor_presentation
Format: PDF investor_presentation
ACETO Corporation announced the acquisition of generic drug-related assets from Citron Pharma and Lucid Pharma on November 3, 2016. The presentation outlines the transaction details, pro forma FY2017 outlook, and financing strategy. This strategic acquisition expands ACETO's portfolio in the generic pharmaceutical sector.
investor_presentation
37 Pages
Manappuram Finance Limited
Teva Pharmaceutical Industries Investor Presentation — November 2020
investor_presentationinvestor_presentation
36 Pages
Teva Pharmaceutical Industries